PARTINGTON FAMILY PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: P91026 | MANCHESTER, M31 4FL
Showing results 51-100 of 595
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Tamsulosin hydrochloride | 802 | 23.1K | £1.0K | -40.8% ▼ |
| Esomeprazole | 791 | 20.2K | £2.5K | +95.5% ▲ |
| Allopurinol | 788 | 27.0K | £636 | -23.5% ▼ |
| Trazodone hydrochloride | 784 | 59.6K | £3.3K | +283.6% ▲ |
| Codeine phosphate | 774 | 67.3K | £2.3K | +7.7% ▲ |
| Famotidine | 716 | 17.9K | £9.5K | +46.7% ▲ |
| Hydrocortisone | 709 | 24.1K | £3.6K | +58.1% ▲ |
| Other emollient preparations | 708 | 415.8K | £5.3K | +17.9% ▲ |
| Mirabegron | 673 | 11.5K | £10.6K | +67.5% ▲ |
| Levetiracetam | 659 | 58.2K | £4.2K | +44.0% ▲ |
| Buprenorphine | 650 | 5,556 | £10.1K | +77.4% ▲ |
| Morphine sulfate | 636 | 67.5K | £4.9K | -3.0% ▼ |
| Olanzapine | 628 | 8,641 | £1.2K | +69.5% ▲ |
| Influenza | 628 | 628 | £9.9K | -60.0% ▼ |
| Ferrous sulfate | 622 | 16.2K | £680 | +21.0% ▲ |
| Alginic acid compound preparations | 619 | 390.0K | £4.6K | +5.7% ▲ |
| Sodium valproate | 618 | 64.3K | £7.2K | +94.3% ▲ |
| Ezetimibe | 608 | 16.5K | £2.9K | -14.5% ▼ |
| Memantine hydrochloride | 602 | 12.0K | £2.9K | +82.2% ▲ |
| Candesartan cilexetil | 582 | 16.9K | £783 | -51.0% ▼ |
| Melatonin | 576 | 38.3K | £13.9K | +73.2% ▲ |
| Ferrous fumarate | 552 | 19.7K | £782 | -23.8% ▼ |
| Indapamide | 533 | 15.9K | £868 | -38.2% ▼ |
| Rivaroxaban | 532 | 11.4K | £7.1K | -13.0% ▼ |
| Thiamine hydrochloride | 524 | 22.7K | £546 | -0.6% vs avg |
| Fluticasone/umeclidinium/vilanterol | 492 | 492 | £20.8K | +109.9% ▲ |
| Valproic acid | 470 | 15.7K | £4.8K | +440.1% ▲ |
| Glucose blood testing reagents | 468 | 32.9K | £5.0K | -40.7% ▼ |
| Hyoscine butylbromide | 459 | 37.7K | £2.6K | +96.9% ▲ |
| 457 | 467 | £20.7K | +47.1% ▲ | |
| Promethazine hydrochloride | 445 | 20.8K | £1.8K | +24.5% ▲ |
| Spironolactone | 444 | 9,956 | £616 | -17.6% ▼ |
| 443 | 4,860 | £3.4K | -33.3% ▼ | |
| Canagliflozin | 442 | 13.3K | £16.6K | +207.8% ▲ |
| 435 | 906 | £30.4K | -20.2% ▼ | |
| Fexofenadine hydrochloride | 422 | 16.8K | £702 | -50.4% ▼ |
| Pramipexole | 405 | 7,321 | £559 | +312.5% ▲ |
| Fluticasone propionate (Inhalation) | 403 | 415 | £9.1K | +4.1% ▲ |
| Clarithromycin | 403 | 12.3K | £2.0K | +64.2% ▲ |
| Oxycodone hydrochloride | 398 | 31.5K | £5.3K | +55.5% ▲ |
| Ranolazine | 396 | 15.7K | £2.9K | +133.0% ▲ |
| Mebeverine hydrochloride | 384 | 32.4K | £1.2K | +23.7% ▲ |
| Atenolol | 384 | 11.9K | £268 | -36.3% ▼ |
| Semaglutide | 377 | 10.7K | £30.0K | +56.6% ▲ |
| Escitalopram | 369 | 11.5K | £637 | +29.7% ▲ |
| Diazepam | 363 | 9,744 | £225 | -27.1% ▼ |
| Umeclidinium bromide/vilanterol | 362 | 386 | £11.9K | +85.6% ▲ |
| Empagliflozin | 359 | 11.0K | £13.7K | -42.6% ▼ |
| Hydroxocobalamin | 359 | 431 | £939 | -25.4% ▼ |
| Topiramate | 356 | 17.1K | £2.3K | +100.3% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.